SOX9/FXYD3/Src Axis Is Critical for ER


Journal

Molecular cancer research : MCR
ISSN: 1557-3125
Titre abrégé: Mol Cancer Res
Pays: United States
ID NLM: 101150042

Informations de publication

Date de publication:
01 2019
Historique:
received: 09 06 2018
revised: 01 08 2018
accepted: 30 08 2018
pubmed: 13 9 2018
medline: 24 1 2020
entrez: 13 9 2018
Statut: ppublish

Résumé

The presence of cancer stem cells (CSC), which possess the ability of self-renewal and cancer initiation, is correlated with poor prognosis and drug resistance of breast cancer patients. But the molecular regulatory networks for maintenance of CSC function still remain unclear. Here, we identified that an estrogen-inducible gene

Identifiants

pubmed: 30206184
pii: 1541-7786.MCR-18-0610
doi: 10.1158/1541-7786.MCR-18-0610
doi:

Substances chimiques

FXYD3 protein, human 0
Membrane Proteins 0
Neoplasm Proteins 0
Receptors, Estrogen 0
SOX9 Transcription Factor 0
SOX9 protein, human 0
src-Family Kinases EC 2.7.10.2

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

238-249

Informations de copyright

©2018 American Association for Cancer Research.

Auteurs

Yue Xue (Y)

Institute of Immunology, Zhejiang University School of Medicine, Hangzhou, China.

Lihua Lai (L)

Institute of Immunology, Zhejiang University School of Medicine, Hangzhou, China.

Wenwen Lian (W)

Institute of Immunology, Zhejiang University School of Medicine, Hangzhou, China.

Xintao Tu (X)

Institute of Immunology, Zhejiang University School of Medicine, Hangzhou, China.

Jiaojiao Zhou (J)

Department of Oncology, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.

Ping Dong (P)

Department of Neurobiology, Institute of Neuroscience, Zhejiang University School of Medicine, Hangzhou, China.

Dan Su (D)

Zhejiang Cancer Hospital, Hangzhou, China.

Xiaojia Wang (X)

Zhejiang Cancer Hospital, Hangzhou, China.

Xuetao Cao (X)

Institute of Immunology, Zhejiang University School of Medicine, Hangzhou, China.
National Key Laboratory of Medical Molecular Biology, Institute of Basic Medical Sciences, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.

Yiding Chen (Y)

Department of Oncology, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.

Qingqing Wang (Q)

Institute of Immunology, Zhejiang University School of Medicine, Hangzhou, China. wqq@zju.edu.cn.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH